NNC6989-0001 A Clinical Trials (2026): 1 Studies for Obesity & Overweight
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 NNC6989-0001 A clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Obesity & Overweight) and 96 total planned enrollment. 1 NNC6989-0001 A clinical trial is actively recruiting at 1 U.S. site across 1 state. Most recent activity: NCT07437079 (Jan 2027).
Where to Participate: All NNC6989-0001 A Trial Sites in the U.S. (1 site across 1 state)
Every actively recruiting NNC6989-0001 Atrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| KS | ICON Early Phase Services, LLC | Lenexa66219 | NCT07437079 | Map |
NNC6989-0001 A clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting NNC6989-0001 A clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07437079 | NNC6989-0001A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity | P1 | Overweight | 96 | Feb 2026 |
All NNC6989-0001 A trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07437079 | NNC6989-0001 | A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity | P1 | recruiting | 96 | Novo Nordisk A/S | Feb 2026 |
NNC6989-0001 A clinical trials: frequently asked questions
- How many NNC6989-0001 A clinical trials are there?
- 1 NNC6989-0001 A clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are NNC6989-0001 A clinical trials recruiting in 2026?
- Yes — 1 NNC6989-0001 A trial is actively recruiting in 2026, with 1 U.S. site across 1 state. See the recruiting trials and the per-state site list further down this page.
- What conditions is NNC6989-0001 A being studied for?
- NNC6989-0001 A is being studied for Obesity, Overweight. The trials are grouped by indication on this page.
- What phase is NNC6989-0001 A in?
- NNC6989-0001 A clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors NNC6989-0001 A clinical trials?
- The lead sponsor across the most NNC6989-0001 A trials is Novo Nordisk A/S. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming NNC6989-0001 Aas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: